Zhao HY - Search Results

1

[Efficacy of erlotinib on advanced non-small cell lung cancer].

Zhao HY, Zhang Y, Huang H, Chen LK, Xu GC, Zhang L. Zhao HY, et al. Ai Zheng. 2008 Apr;27(4):393-9. Ai Zheng. 2008. PMID: 18423126 Free article. Chinese.

2

[Review of relationship between tumor necrosis factor genetic polymorphism and hematological malignancies].

Zhao HY, Chen YX. Zhao HY, et al. Ai Zheng. 2003 Feb;22(2):216-20. Ai Zheng. 2003. PMID: 12600304 Review. Chinese.

3

[Relationship between tumor necrosis factor genetic polymorphisms and acute lymphocytic leukemia].

Zhao HY, Chen YX, Lin XB, Zhong XY, Zhong LY, Ou RM, Jiang WQ, Guan ZZ. Zhao HY, et al. Ai Zheng. 2003 Aug;22(8):861-6. Ai Zheng. 2003. PMID: 12917036 Chinese.

4

[Efficacy of gefitinib on Chinese patients with locally advanced or metastatic non-small cell lung cancer: a clinical trial].

Guan ZZ, Zhang L, Li LY, Jiang GL, Liu XY, Chu DT, Zhao HY, Li W. Guan ZZ, et al. Among authors: zhao hy. Ai Zheng. 2005 Aug;24(8):980-4. Ai Zheng. 2005. PMID: 16086877 Clinical Trial. Chinese.

5

[Randomized controlled trial of two kinds of home-produced docetaxel in China for advanced breast cancer].

Liu DG, Peng RJ, Feng FY, Hu XH, Tang GD, Xiong JP, Zhao HY, Guo Y, Guan ZZ. Liu DG, et al. Among authors: zhao hy. Ai Zheng. 2006 Dec;25(12):1557-60. Ai Zheng. 2006. PMID: 17166386 Clinical Trial. Chinese.

6

[Efficacy of gefitinib on advanced non-small cell lung cancer in expanded access program (EAP)].

Zhang Y, Zhang L, Xu F, Wang ZQ, Zhao HY, Guan ZZ, Xu GC, Pan ZK. Zhang Y, et al. Among authors: zhao hy. Ai Zheng. 2006 Dec;25(12):1561-4. Ai Zheng. 2006. PMID: 17166387 Chinese.

7

Predictive significance of bone sialoprotein and osteopontin for bone metastases in resected Chinese non-small-cell lung cancer patients: a large cohort retrospective study.

Zhang L, Hou X, Lu S, Rao H, Hou J, Luo R, Huang H, Zhao H, Jian H, Chen Z, Liao M, Wang X. Zhang L, et al. Lung Cancer. 2010 Jan;67(1):114-9. doi: 10.1016/j.lungcan.2009.03.017. Lung Cancer. 2010. PMID: 19376608

8

[Analysis of the efficacy and safety of gefitinib in the treatment of recurrent advanced non-small cell lung cancer in an expanded access program (EAP)].

Huang H, Zhang Y, Zhao HY, Wang ZQ, Xu F, Xu GC, Zhang L, Guan ZZ. Huang H, et al. Among authors: zhao hy. Zhonghua Zhong Liu Za Zhi. 2009 Feb;31(2):148-51. Zhonghua Zhong Liu Za Zhi. 2009. PMID: 19538895 Chinese.

9

[Predictive factors for response and survival of gefitinib-treated locally advanced or metastatic non-small cell lung cancer patients: a retrospective analysis of two phase II clinical trials].

Zhao YY, Zhang Y, Zhao HY, Wu JX, Jiang W, Xue C, Zhang L. Zhao YY, et al. Among authors: zhao hy. Ai Zheng. 2009 Jun;28(6):626-31. Ai Zheng. 2009. PMID: 19635201 Free article. Chinese.

10

Validation of a clinical prognostic model in Chinese patients with metastatic and advanced pretreated non-small cell lung cancer treated with gefitinib.

Wang F, Zhang Y, Zhao H, Chen L, Shi YX, Zhang L. Wang F, et al. Med Oncol. 2011 Mar;28(1):331-5. doi: 10.1007/s12032-010-9451-1. Epub 2010 Mar 4. Med Oncol. 2011. PMID: 20204544

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,094 results

Search Page

Filters